Nutritional Risk Screening and Analysis of Clinical Outcomes in Hospitalized Patients with Hepatobiliary and Pancreatic Diseases

翟茂东,杨俊,贾震易,秦环龙
DOI: https://doi.org/10.3969/j.issn.1007-1954.2012.03.002
2012-01-01
Abstract:Objective To investigate nutritional risk and nutritional support in hospitalized patients with hepatobiliary and pancreatic diseases,and to analyze the relationship between nutritional risk and clinical outcomes.Methods In this prospective cohort study,patients with hepatobiliary and pancreatic diseases were recruited from July 2011 to January 2012.Patients were screened using Nutritional Risk Screening 2002(NRS2002) at admission.Data of the nutritional risk,application of nutritional support,complications and duration of hospitalzation were collected.Results Four hundred and eleven patients with hepatobiliary and pancreatic diseases were recruited,the overall prevalence of nutritional risk was 20.6% at admission,59.3% in liver cancer,32% in the bile duct cancer,while the lowest nutritional risk was found in liver cysts(4.4%).The rate of complications in the patients with nutritional risk was higher than that in the patients without nutritional risk(44.7% vs 19.6%,P 0.001).Serious complications in patients with nutritional risk had no significantly different with patients without nutritional risk(34.2% vs 32.8 %,P =0.885).For the patients with nutritional risk,the complications rates and the average duration of hospitalzation in patients with nutritional support were significantly lower than those without nutritional support(38.1% vs 63.6%,P =0.038;15.41 ± 2.47 d vs 17.00 ± 3.38 d,P =0.021);For the patients without nutritional risk,the complications of patients with nutritional support was significantly higher than those without nutritional suppor(t21.9% vs 17.5%,P =0.319),while the average duration of hospitalzation of patients with nutritional support was significantly longer than those without nutritional support(12.75 ±2.63 d vs 11.75 ±2.97 d,P =0.002).Conclusion Patients with hepatobiliary and pancreatic diseases have a higher nutritional risk in malignant disease,and patients with nutritional risk have more complications;nutritional support is beneficial to the patients with nutritional risk by improving clinical outcomes.
What problem does this paper attempt to address?